iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,740.00
-45.00 (-1.19%)
Apr 29, 2026, 3:30 PM KST

iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 119.66 billion as of April 29, 2026. Its market cap has increased by 7.12% in one year.

Market Cap
119.66B
Enterprise Value
81.24B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,740.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 119.66B, an increase of 25.56%. That is a compound annual growth rate of 1.50%.

History

DateMarket Cap% Change
Apr 28, 2026119.66B16.46%
Dec 30, 2025102.75B-44.03%
Dec 30, 2024183.56B-37.01%
Dec 28, 2023291.42B7.98%
Dec 29, 2022269.88B-61.99%
Dec 30, 2021710.00B-22.41%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Oncocross 111.59B
Prestige BioPharma 108.89B
Amicogen 133.16B
IMB Dx 99.95B
CG Invites 97.66B
GeneOne Life Science 83.06B
Vaxcell-Bio Therapeutics 178.38B
ENCell 181.08B
Market Cap Rankings